Cue Biopharma Welcomes Michael J. Fox to Board, Shareholders Vote
Company Announcements

Cue Biopharma Welcomes Michael J. Fox to Board, Shareholders Vote

The latest announcement is out from Cue Biopharma (CUE).

Michael J. Fox was appointed to the board of Cue Biopharma, Inc. and will be compensated under the company’s policy, including stock options vesting over three years. His appointment followed proper corporate governance with no conflicting arrangements. Additionally, Cue Biopharma’s Annual Meeting saw the election of board members, the ratification of their accounting firm, and approval of executive compensation, demonstrating active shareholder engagement and oversight.

For a thorough assessment of CUE stock, go to TipRanks’ Stock Analysis page.

Related Articles
Catie PowersCUE Upcoming Earnings Report: What to Expect?
TheFlyCue Biopharma presents ‘positive’ update from Phase 1 trials of CUE-101, CUE-102
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App